Mon, Dec 22, 2014
A A A
Welcome Guest
Free Trial RSS
Get FREE trial access to our award winning publications
Industry Updates

IndexIQ's Hedge Composite Beta Index up 0.86% in April, 1.18% YTD

Friday, May 03, 2013
Opalesque Industry Update - IndexIQ, a leading developer of index-based alternative investment solutions, announces the performance of its proprietary family of hedge fund replication and alternative beta indexes for April 2013.

Designed as investable benchmarks that replicate the performance characteristics of sophisticated hedge fund strategies, the IQ Hedge™ benchmark indexes were originally introduced on March 30, 2007, and have been calculating live since that date. IQ Hedge is the first family of investable benchmark indexes covering hedge fund replication/alternative beta strategies.

For the period ended April 30, 2013, the returns for the indexes were as follows:

IQ HEDGE FUND REPLICATION - Beta Indexes

 

 

 

 

1 Month

 

3 Month

 

YTD

 

1 Year

 

3 Year

 

5 Year

IQ Hedge Global Macro Beta Index

 

IQHGGMB

 

-0.62%

 

-0.07%

 

-1.25%

 

-0.14%

 

3.07%

 

2.03%

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

IQ Hedge Long/Short Beta Index

 

IQHGLSB

 

0.26%

 

1.58%

 

3.38%

 

9.14%

 

6.23%

 

-0.11%

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

IQ Hedge Event-Driven Beta Index

 

IQHGEDB

 

1.97%

 

1.31%

 

1.22%

 

4.55%

 

4.73%

 

3.16%

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

IQ Hedge Market Neutral Beta Index

 

IQHGMNB

 

1.43%

 

1.23%

 

1.58%

 

3.35%

 

2.19%

 

2.31%

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

IQ Hedge Emerging Markets Beta Index

 

IQHGEMB

 

0.93%

 

-0.93%

 

-1.61%

 

0.76%

 

0.47%

 

4.36%

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

IQ Hedge Fixed Income Arbitrage Beta Index

 

IQHGFIB

 

1.23%

 

3.30%

 

3.77%

 

7.30%

 

5.02%

 

4.28%

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

IQ Hedge Composite Beta Index

 

IQHGCOB

 

0.86%

 

1.08%

 

1.18%

 

4.17%

 

3.69%

 

2.80%

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Performance greater than one year is annualized. Past performance does not guarantee future results.

IndexIQ is a leading issuer of index-based liquid alternative solutions focused on absolute return, real asset and international strategies. IndexIQ solutions are offered as ETFs, Mutual Funds, Separate Accounts and Model Portfolios. IndexIQ’s philosophy is to democratize investment management by making innovative alternative investment strategies available to investors in low cost, liquid and transparent products. IndexIQ strategies are marketed through the company’s proprietary investment products and select partnerships with leading global financial institutions. www.IndexIQ.com.

Bg

What do you think?

   Use "anonymous" as my name    |   Alert me via email on new comments   |   
Today's Exclusives Today's Other Voices More Exclusives
Previous Opalesque Exclusives                                  
More Other Voices
Previous Other Voices                                               
Access Alternative Market Briefing


  • Top Forwarded
  • Top Tracked
  • Top Searched
  1. Investing - Big hedge funds win again on PetSmart, Riverbed, RBS sells real estate loans to hedge fund Cerberus, Talisman energy speculation: Which hedge funds could benefit?[more]

    Big hedge funds win again on PetSmart, Riverbed From CNBC.com: Another week, another set of wins for activist investors. On Sunday, pet supply retailer PetSmart agreed to the largest leveraged buyout of the year at $8.7 billion. Hedge fund firm JANA Partners had been pushing for a sale a

  2. Outlook - Hedge fund manager who remembers 1998 rout says prepare for pain, Bond guru Bill Gross predicts U.S. economic growth to dip to 2%[more]

    Hedge fund manager who remembers 1998 rout says prepare for pain From Bloomberg.com: Stephen Jen landed in Hong Kong in early January 1997 as Morgan Stanley’s newly minted exchange-rate strategist for Asia. He was soon working around the clock when investors began targeting the region’s

  3. Investing - Hedge funds get boost from healthcare in 2014, Paulson & Co takes stake in Salix on heels of inventory issues[more]

    Hedge funds get boost from healthcare in 2014 From Valuewalk.com: The healthcare sector started the year on a turbulent note, as stocks of many major biotechnology companies were battered. However, most of the players in this sector have bounced back. The BarclayHedge Healthcare & Biotec

  4. North America - Why Steve Cohen, Connecticut hedge fund billionaire, gives so much in New York[more]

    From Insidephilantrophy.com: Billionaire Steve Cohen was born in Great Neck, New York before attending Wharton, working on Wall Street and then founding SAC Capital Advisors in Connecticut. Though his company (Point72) and foundation are based in Connecticut, Cohen and Alexandra are deeply connected

  5. Investing - Soros buys a highly speculative biotech in the third quarter[more]

    From Fool.com: …The Soros Fund bought 25,000 shares of the struggling small-cap biopharma Aegerion Pharmaceuticals in the third quarter. For those of you who haven't heard of this name, suffice to say that this was a surprising buy in light of the company's recent problems and poor outlook going for